Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Ischemic Heart Disease

  Free Subscription


3 Am Heart J
4 Am J Cardiol
2 Am J Med
2 Angiology
2 Ann Intern Med
4 Atherosclerosis
1 Can J Cardiol
1 Cardiovasc Res
14 Catheter Cardiovasc Interv
2 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Interv
3 Circ Res
3 Circulation
1 Clin Cardiol
4 Eur Heart J
3 Heart
1 Hypertension
3 Int J Cardiol
4 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Mol Cell Cardiol
1 J Thorac Cardiovasc Surg
1 Lancet Diabetes Endocrinol
5 N Engl J Med
1 PLoS One
2 Prog Cardiovasc Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. KUNO T, Takahashi M, Obata R, Maeda T, et al
    Cardiovascular comorbidities, cardiac injury and prognosis of COVID-19 in New York City.
    Am Heart J. 2020 May 15. pii: S0002-8703(20)30141.
    PubMed         Abstract available

  2. LOUNGANI RS, Rehorn MR, Newby LK, Katz JN, et al
    A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response.
    Am Heart J. 2020;225:3-9.
    PubMed         Abstract available

  3. DEHGHANI P, Davidson LJ, Grines CL, Nayak K, et al
    North American COVID-19 ST-segment elevation myocardial infarction (NACMI) registry: Rationale, design, and implications.
    Am Heart J. 2020 May 16. pii: S0002-8703(20)30142.
    PubMed         Abstract available

    Am J Cardiol

  4. VAVIK V, Pedersen EKR, Svingen GF, Solheim E, et al
    Systemic Cardiac Troponin T Associated With Incident Atrial Fibrillation Among Patients With Suspected Stable Angina Pectoris.
    Am J Cardiol. 2020 Apr 12. pii: S0002-9149(20)30325.
    PubMed         Abstract available

  5. AGGARWAL G, Henry BM, Aggarwal S, Bangalore S, et al
    Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
    Am J Cardiol. 2020 May 16. pii: S0002-9149(20)30489.
    PubMed         Abstract available

  6. GRUBLER MR, Delgado G, Kleber M, Hartaigh BO, et al
    Effect of Galectin 3 on Aldosterone-Associated Risk of Cardiovascular Mortality in Patients Undergoing Coronary Angiography.
    Am J Cardiol. 2020 Apr 22. pii: S0002-9149(20)30385.
    PubMed         Abstract available

  7. CHANDRASEKHAR J, Sartori S, Aquino MB, Baber U, et al
    Comparison of One-Year Outcomes in Patients >75 Versus
    Am J Cardiol. 2020 Apr 24. pii: S0002-9149(20)30382.
    PubMed         Abstract available

    Am J Med

  8. TAN BE, Chowdhury M, Hall C, Baibhav B, et al
    Exogenous testosterone abuse and myocardial infarction in a young bodybuilder.
    Am J Med. 2020 May 13. pii: S0002-9343(20)30368.

  9. LIU J, Elbadawi A, Elgendy IY, Megaly M, et al
    Age-Stratified Sex Disparities in Care and Outcomes in Patients with ST-elevation Myocardial Infarction.
    Am J Med. 2020 May 14. pii: S0002-9343(20)30375.
    PubMed         Abstract available


  10. BOURAZANA A, Xanthopoulos A, Skoularigis J, Triposkiadis F, et al
    Preoperative Antiplatelet Therapy and Bleeding Risk in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting: A Fine Balance.
    Angiology. 2020 May 20:3319720925973. doi: 10.1177/0003319720925973.

  11. MOHAMED TI, Baqal OJ, Binzaid AA, Belhaj K, et al
    Outcomes of Routine Coronary Angiography in Asymptomatic Patients With End-Stage Renal Disease Prior to Kidney Transplantation.
    Angiology. 2020 May 20:3319720927239. doi: 10.1177/0003319720927239.
    PubMed         Abstract available

    Ann Intern Med

    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707.

  13. PARK S, Han K, Kim DK
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707-708.


  14. TOYA T, Corban MT, Imamura K, Bois JP, et al
    Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction.
    Atherosclerosis. 2020;302:27-35.
    PubMed         Abstract available

  15. LIU X, Li J, Liao J, Wang H, et al
    Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr(-/-) mice.
    Atherosclerosis. 2019;282:100-109.
    PubMed         Abstract available

  16. ZHAO Y, Evans MA, Allison MA, Bertoni AG, et al
    Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2018 Dec 15. pii: S0021-9150(18)31525.
    PubMed         Abstract available

  17. PLANAS-BALLVE A, Crespo AM, Aguilar LM, Hernandez-Perez M, et al
    The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.
    Atherosclerosis. 2019;282:132-136.
    PubMed         Abstract available


    Covid-19 and cardiovascular disease.
    BMJ. 2020;369:m1997.
    PubMed         Abstract available

    Can J Cardiol

  19. JACKEVICIUS CA, Krumholz HM, Ross JS, Koh M, et al
    Clinical Outcomes With Beta-Blocker Use in Patients With Recent History of Myocardial Infarction.
    Can J Cardiol. 2020 Feb 4. pii: S0828-282X(20)30060.
    PubMed         Abstract available

    Cardiovasc Res

  20. ROE AT, Ruud M, Espe EK, Manfra O, et al
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.
    Cardiovasc Res. 2018 Oct 23. pii: 5142689. doi: 10.1093.
    PubMed         Abstract available

    Catheter Cardiovasc Interv

  21. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed         Abstract available

  22. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed         Abstract available

  23. HE Y, Zhang D, Yin D, Zhu C, et al
    Development and validation of a risk scoring system based on baseline angiographic results by visual estimation for risk prEdiction of side-branch OccLusion in coronary bifurcation InterVEntion: The baseline V-RESOLVE score.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28068.
    PubMed         Abstract available

  24. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed         Abstract available

  25. DERIMAY F, Rioufol G, Finet G
    Letter by Derimay et al regarding the article: "Coronary bifurcation bench test using multimodality imaging: Impact of stent strut link location on stent deformity and jailed side-branch orifices during reproximal optimizing technique" by Kume et al.
    Catheter Cardiovasc Interv. 2019 Mar 6. doi: 10.1002/ccd.28178.

  26. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed         Abstract available

  27. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.

  28. SHAH R, Naz A
    Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 26. doi: 10.1002/ccd.28377.

  29. HARARI R, Bangalore S, Chang E, Shah B, et al
    COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28992.
    PubMed         Abstract available

  30. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed         Abstract available

  31. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed         Abstract available

  32. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed         Abstract available

  33. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
    PubMed         Abstract available

  34. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed         Abstract available

    Circ Arrhythm Electrophysiol

  35. OREN O, Yang EH, Gluckman TJ, Michos ED, et al
    The Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
    Circ Arrhythm Electrophysiol. 2020 May 21. doi: 10.1161/CIRCEP.120.008688.

  36. TULPPO MP, Kiviniemi AM, Lahtinen M, Ukkola O, et al
    Physical Activity and the Risk for Sudden Cardiac Death in Patients with Coronary Artery Disease.
    Circ Arrhythm Electrophysiol. 2020 May 20. doi: 10.1161/CIRCEP.119.007908.
    PubMed         Abstract available

    Circ Cardiovasc Interv

  37. CHEVALIER B, Abizaid A, Carrie D, Frey N, et al
    Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold.
    Circ Cardiovasc Interv. 2019;12:e007283.
    PubMed         Abstract available

    Circ Res

  38. PICHE ME, Tchernof A, Despres JP
    Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.
    Circ Res. 2020;126:1477-1500.
    PubMed         Abstract available

  39. MARINKOVIC G, Koenis D, de Camp L, Jablonowski R, et al
    S100A9 Links Inflammation and Repair in Myocardial Infarction.
    Circ Res. 2020 May 21. doi: 10.1161/CIRCRESAHA.120.315865.
    PubMed         Abstract available

  40. GOODARZI MO, Rotter JI
    Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.
    Circ Res. 2020;126:1526-1548.
    PubMed         Abstract available


  41. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    PubMed         Abstract available

  42. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay.
    Circulation. 2018 Nov 6:CIR0000000000000628. doi: 10.1161/CIR.0000000000000628.

  43. BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
    Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
    PubMed         Abstract available

    Clin Cardiol

  44. XIONG R, He L, Du X, Dong JZ, et al
    Impact of diabetes mellitus and hemoglobin A1c level on outcomes among Chinese patients with acute coronary syndrome.
    Clin Cardiol. 2020 May 19. doi: 10.1002/clc.23373.
    PubMed         Abstract available

    Eur Heart J

  45. MEHRAN R, Kalkman DN, Angiolillo DJ
    Atrial fibrillation, with ACS and PCI: walking a tightrope.
    Eur Heart J. 2019 Apr 8. pii: 5431179. doi: 10.1093.

  46. CHIEFFO A, Stefanini GG, Price S, Barbato E, et al
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
    Eur Heart J. 2020;41:1839-1851.
    PubMed         Abstract available

  47. METZLER B, Siostrzonek P, Binder RK, Bauer A, et al
    Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.
    Eur Heart J. 2020;41:1852-1853.

  48. CAMPO G, Rapezzi C, Tavazzi L, Ferrari R, et al
    Priorities for Cath labs in the COVID-19 tsunami.
    Eur Heart J. 2020;41:1784-1785.


  49. KOENRAADT WMC, Siebelink HJ, Bartelings MM, Schalij MJ, et al
    Coronary anatomy in Turner syndrome versus patients with isolated bicuspid aortic valves.
    Heart. 2018 Oct 27. pii: heartjnl-2018-313724. doi: 10.1136/heartjnl-2018-313724
    PubMed         Abstract available

  50. PALM P, Zwisler AO, Svendsen JH, Thygesen LC, et al
    Sexual rehabilitation for cardiac patients with erectile dysfunction: a randomised clinical trial.
    Heart. 2018 Oct 31. pii: heartjnl-2018-313778. doi: 10.1136/heartjnl-2018-313778
    PubMed         Abstract available

  51. DU FAY DE LAVALLAZ J, Puelacher C, Lurati Buse G, Bolliger D, et al
    Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect on outcome.
    Heart. 2018 Dec 12. pii: heartjnl-2018-313876. doi: 10.1136/heartjnl-2018-313876
    PubMed         Abstract available


  52. INOUE K, Goldwater D, Allison M, Seeman T, et al
    Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis.
    Hypertension. 2020 May 18:HYPERTENSIONAHA12015006.
    PubMed         Abstract available

    Int J Cardiol

  53. LIN CF, Chang YH, Su CH, Liu HY, et al
    Risk of new-onset atrial fibrillation after drug-eluting stent implantation in patients with stable coronary artery disease.
    Int J Cardiol. 2019 May 23. pii: S0167-5273(19)31210.
    PubMed         Abstract available

  54. SCHAFER A, Werner N, Westenfeld R, Moller JE, et al
    Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock - A European experienced users working group opinion.
    Int J Cardiol. 2019 May 21. pii: S0167-5273(19)31855.
    PubMed         Abstract available

  55. HE C, Zhu C, Zhu Y, Zou Z, et al
    Effect of exercise-based cardiac rehabilitation on clinical outcomes in patients with myocardial infarction in the absence of obstructive coronary artery disease (MINOCA): A prospective cohort study.
    Int J Cardiol. 2020 May 13. pii: S0167-5273(20)30806.
    PubMed         Abstract available

    J Am Coll Cardiol

  56. WELT FGP, Shah PB, Aronow HD, Bortnick AE, et al
    Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.
    J Am Coll Cardiol. 2020;75:2372-2375.

  57. PATEL KK, Spertus JA, Arnold SV, Chan PS, et al
    Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization.
    J Am Coll Cardiol. 2019;74:1734-1736.

    What Is of Recent Interest in Cardiac CT: Insights From the JACC Family of Journals.
    J Am Coll Cardiol. 2019;73:3352-3355.

  59. KWONG RY, Ge Y, Steel K, Bingham S, et al
    Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain.
    J Am Coll Cardiol. 2019;74:1741-1755.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  60. ZHANG C, Yang JB, Quan W, Feng YD, et al
    Activation of Paraventricular Melatonin Receptor 2 Mediates Melatonin- conferred Cardio-protection Against Myocardial Ischemia/Reperfusion Injury.
    J Cardiovasc Pharmacol. 2020 May 13. doi: 10.1097/FJC.0000000000000851.
    PubMed         Abstract available

    J Mol Cell Cardiol

  61. CUI G, Tian M, Hu S, Wang Y, et al
    Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease.
    J Mol Cell Cardiol. 2020;144:54-62.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  62. MITTEL A, Kim DH, Cooper Z, Argenziano M, et al
    Use of 90-day mortality does not change assessment of hospital quality after coronary artery bypass grafting in New York State.
    J Thorac Cardiovasc Surg. 2020 Apr 11. pii: S0022-5223(20)30765.
    PubMed         Abstract available

    Lancet Diabetes Endocrinol

  63. RAAL FJ, Mohamed F
    More aggressive lipid lowering in people with diabetes?
    Lancet Diabetes Endocrinol. 2019 Jul 1. pii: S2213-8587(19)30190.

    N Engl J Med

  64. FERRO CJ, Sarafidis P, Ortiz A
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.

  65. SOLOMON MD, McNulty EJ, Rana JS, Leong TK, et al
    The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMc2015630.

  66. TSIMIKAS S, Karwatowska-Prokopczuk E, Xia S
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply.
    N Engl J Med. 2020;382:e65.

  67. ANDREOTTI F, Maggioni AP
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.

    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.

    PLoS One

  69. REANO JDP, Shiu LAB, Miralles KV, Dimalala MGC, et al
    A systematic review and meta-analysis on the effectiveness of an invasive strategy compared to a conservative approach in patients > 65 years old with non-ST elevation acute coronary syndrome.
    PLoS One. 2020;15:e0229491.
    PubMed         Abstract available

    Prog Cardiovasc Dis

  70. YOUSUF T, Nakhle A, Rawal H, Harrison D, et al
    Natural disasters and acute myocardial infarction.
    Prog Cardiovasc Dis. 2020 May 14. pii: S0033-0620(20)30099.
    PubMed         Abstract available

  71. DESAI AS, Kamdar BB, Mehra MR
    Palliative care considerations for cardiovascular clinicians in COVID-19.
    Prog Cardiovasc Dis. 2020 May 8. pii: S0033-0620(20)30098.

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.